Threshold, FDA Reach Agreement On TH-302 Trial SPA
Threshold Pharmaceuticals announced agreement with the FDA on a special protocol assessment for planned Phase 3 TH-302 combination trial in advanced soft-tissue sarcoma.
Read MoreSearch Results for: leukemia
Biocare, Jackson Foundation Strike Exclusive Distribution Agreement
Biocare Medical and the Henry M Jackson Foundation for the Advancement of Military Medicine announce exclusive distribution agreement for a highly specific monoclonal antibody.
Read More
Product Showcase
Multiplex Lyme, Syphilis, and ToRCH IgG The AtheNA Multi-Lyte® menu offered by Alere Inc, Waltham, Mass, includes three new infectious disease assays. Borrelia VlsE-1/ pepC10 is used as a first-tier test to detect qualitative levels of B. bu
Read MoreStudy: Cancer Molecular Testing Will Show Above Average Revenue Growth
Cancer tests based on detecting DNA changes and patterns will show above average revenue growth over other forms of testing, according to health care market research publisher Kalorama Information.
Read MoreMyconostica Presents Clinical Evaluation Data For Mycassay Pneumocystis
Myconostica Ltd presented positive data from a multi-centre prospective evaluation of MycAssay Pneumocystis, the Companys CE marked diagnostic product for detection of Pneumocystis DNA in respiratory samples.
Read More